Discovery of novel thiosemicarbazone dimers as effective inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1) for use in cancer therapy.

Documenti analoghi

• The Potential of PARP Inhibitors as Antitumor Drugs and the Perspective of Molecular Design.
  di: Wang, Yinghan, et al.
  Pubblicazione: (2025)
• Subcellular NAD pools are interconnected and buffered by mitochondrial NAD.
  di: Høyland, Lena E, et al.
  Pubblicazione: (2024)
• Discovery of 4-(2-(methylamino)thiazol-5-yl)pyrimidin-2-amine derivatives as novel cyclin-dependent kinase 12 (CDK12) inhibitors for the treatment of esophageal squamous cell carcinoma.
  di: Cao, Yin, et al.
  Pubblicazione: (2025)
• The evolving chemistry of cADPR analogues: from marine discovery to calcium signaling tools.
  di: Falanga, Andrea Patrizia, et al.
  Pubblicazione: (2025)
• Discovery of an orally bioavailable pyridone-based BRD4 inhibitor with potent antitumor efficacy in colorectal cancer.
  di: Fang, Zhangyun, et al.
  Pubblicazione: (2026)